Promoting tobacco cessation by integrating 'brief advice' in tuberculosis control programme
Jagdish Kaur1, Kuldeep S Sachdeva1, Bhavesh Modi2
1Ministry of Health and Family Welfare, Government of India, India.
WHO South-East Asia Journal of Public Health
|June 15, 2017
Summary
Integrating brief advice for tobacco cessation into tuberculosis (TB) treatment in India significantly increased quit rates. This cost-effective intervention shows feasibility for TB control programmes.
Area of Science:
- Public Health
- Tobacco Control
- Tuberculosis Management
Background:
- Co-prevalence of tuberculosis (TB) and tobacco use poses a significant health burden in India.
- Tobacco use adversely impacts the effectiveness of TB control programs.
- Addressing tobacco cessation is crucial for improving TB treatment outcomes.
Purpose of the Study:
- To assess the feasibility and effectiveness of integrating 'brief advice' for tobacco cessation into routine TB care.
- To promote tobacco cessation among tobacco-using TB patients in Vadodara, Gujarat, India.
- To evaluate a cost-effective intervention for tobacco cessation within TB control programs.
Main Methods:
- Incorporated WHO and The Union's 'five A's' brief advice strategy into the ongoing TB Control Programme.
- Developed educational and data capture tools for the intervention.
- Offered brief advice to registered TB patients on directly observed treatment short-course (DOTS) who used tobacco.
Main Results:
- 46.3% of TB patients were current tobacco users (predominantly male).
- Among patients offered brief advice, 67.3% quit tobacco use by the end of treatment.
- Relapse and loss to follow-up rates were 18.2% and 14.5%, respectively.
Conclusions:
- Integrating brief advice is a feasible and cost-effective strategy for tobacco cessation in TB patients.
- The intervention shows potential to improve TB control program outcomes.
- Careful monitoring is essential for successful implementation of tobacco cessation interventions in TB patients.
Related Concept Videos
01:28Pulmonary Tuberculosis V
691
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
691
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
01:26Pulmonary Tuberculosis IV
575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K